Sesen Bio Inc
Change company Symbol lookup
Select an option...
SESN Sesen Bio Inc
$R25IGTRI Russell 2500 Growth TR Index
QQQ Invesco QQQ Trust
PRDO Perdoceo Education Corp
DITHF DS Smith PLC
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
ASTA WorldFlix Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Sesen Bio, Inc. is a late-stage clinical company providing targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. Its product pipeline includes Vicinium, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The Company's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process.

Closing Price
$0.9578
Day's Change
0.0747 (8.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.01
Day's Low
0.87
Volume
(Heavy Day)
Volume:
17,781,410

10-day average volume:
11,742,831
17,781,410
  • Prev Close
    0.8831
  • Today's Open
    0.8889
  • Day's Range
    0.87-1.01
  • Avg Vol (10-day)
    11.7M
  • Last (time)
    4:00p ET 10/15/21
  • Last (size)
    350
  • 52-Wk Range
    0.70 - 6.04
    LowHigh
  • (08/13/21 - 08/13/21)
    36.83%
  • 137.5%
  • Market Cap
    187.7M
  • Shares Outstanding
    196.0M
  • -0.80
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 32.84
  • (% of float 09/30/21)
    3.91

Latest News

October 15, 2021
10:50 pm ET
BusinessWire
9:00 pm ET
BusinessWire
7:37 pm ET
Accesswire
6:36 pm ET
Newsfile
5:58 pm ET
Accesswire
4:28 pm ET
Newsfile
3:54 pm ET
Newsfile
3:30 pm ET
Accesswire
3:00 pm ET
Newsfile
1:10 pm ET
BusinessWire
1:00 pm ET
Globe Newswire
9:01 am ET
Accesswire
9:00 am ET
Accesswire
8:26 am ET
Accesswire
October 14, 2021
11:46 pm ET
Newsfile
10:35 pm ET
Accesswire
7:45 pm ET
Accesswire
6:27 pm ET
Newsfile
4:26 pm ET
Newsfile
2:54 pm ET
PR Newswire
2:30 pm ET
Accesswire
12:14 pm ET
PR Newswire
11:00 am ET
BusinessWire
10:06 am ET
Globe Newswire
8:20 am ET
Accesswire
5:23 am ET
Newsfile
October 13, 2021
10:00 pm ET
Globe Newswire
7:10 pm ET
Accesswire
6:16 pm ET
Newsfile
6:15 pm ET
Globe Newswire
5:52 pm ET
Newsfile
4:15 pm ET
Newsfile
4:10 pm ET
Accesswire
3:21 pm ET
Accesswire
1:37 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.